Education
About Us
Working with TipRanks
Follow Us
RUA Life Sciences (GB:RUA)
LSE:RUA
RESEARCH TOOLSreports
RUA Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.89p - 15.70p
Previous CloseN/A
Volume378.53K
Average Volume (3M)91.89K
Market Cap
£7.14M
Enterprise Value5.90M
Total Cash (Recent Filing)£2.41M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)34.8
Beta0.49
Next Earnings
Jul 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding62,060,272
10 Day Avg. Volume63,325
30 Day Avg. Volume91,886
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.51
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
RUA Life Sciences News
PremiumCompany Announcements
RUA Life Sciences Reports Robust Revenue Growth and Strategic Expansion
PremiumCompany Announcements
RUA Life Sciences CEO Increases Stake in Company
PremiumCompany Announcements
RUA Life Sciences CEO Increases Shareholding
PremiumCompany Announcements
RUA Life Sciences Achieves Significant Revenue and Profit Growth in H1 2024
PremiumCompany Announcements
RUA Life Sciences Sees Strong Revenue Growth
PremiumCompany Announcements
RUA Life Sciences Acquires Medical Device Firm AbissPremiumCompany Announcements
RUA Life Sciences AGM Concludes with Full Approval---
Options Prices
Currently, No data available
---
Ownership Overview
1.46% Insiders
―
Mutual Funds
― Other Institutional Investors
98.54% Public Companies and
Individual Investors
RUA FAQ
What was RUA Life Sciences’s price range in the past 12 months?
RUA Life Sciences lowest share price was 9.88p and its highest was 15.70p in the past 12 months.
What is RUA Life Sciences’s market cap?
RUA Life Sciences’s market cap is £7.14M.
When is RUA Life Sciences’s upcoming earnings report date?
RUA Life Sciences’s upcoming earnings report date is Jul 22, 2025 which is in 89 days.
How were RUA Life Sciences’s earnings last quarter?
RUA Life Sciences released its earnings results on Dec 11, 2024. The company reported 0.01p earnings per share for the quarter, beating the consensus estimate of N/A by 0.01p.
Is RUA Life Sciences overvalued?
According to Wall Street analysts RUA Life Sciences’s price is currently Overvalued.
Does RUA Life Sciences pay dividends?
RUA Life Sciences does not currently pay dividends.
What is RUA Life Sciences’s EPS estimate?
RUA Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RUA Life Sciences have?
RUA Life Sciences has 62,060,272 shares outstanding.
What happened to RUA Life Sciences’s price movement after its last earnings report?
RUA Life Sciences reported an EPS of 0.01p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.77%.
Which hedge fund is a major shareholder of RUA Life Sciences?
Currently, no hedge funds are holding shares in GB:RUA
---
Company Description
RUA Life Sciences
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
---
Technical Analysis
Advanced Medical Solutions
―
Scancell Holdings
―
Tissue Regenix
―
Polarean Imaging
―
Renalytix
―
---